Paper
13 March 2013 Validation of diffuse optical tomography using a bi-functional optical-MRI contrast agent and a hybrid MRI-DOT system
Alex T. Luk, Yuting Lin, Brian Grimmond, Anup Sood, Egidijus E. Uzgiris, Orhan Nalcioglu, Gultekin Gulsen
Author Affiliations +
Proceedings Volume 8574, Multimodal Biomedical Imaging VIII; 85740K (2013) https://doi.org/10.1117/12.2003606
Event: SPIE BiOS, 2013, San Francisco, California, United States
Abstract
Since diffuse optical tomography (DOT) is a low spatial resolution modality, it is desirable to validate its quantitative accuracy with another well-established imaging modality, such as magnetic resonance imaging (MRI). In this work, we have used a polymer based bi-functional MRI-optical contrast agent (Gd-DTPA-polylysine-IR800) in collaboration with GE Global Research. This multi-modality contrast agent provided not only co-localization but also the same kinetics, to cross-validate two imaging modalities. Bi-functional agents are injected to the rats and pharmacokinetics at the bladder are recovered using both optical and MR imaging. DOT results are validated using MRI results as "gold standard"
© (2013) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Alex T. Luk, Yuting Lin, Brian Grimmond, Anup Sood, Egidijus E. Uzgiris, Orhan Nalcioglu, and Gultekin Gulsen "Validation of diffuse optical tomography using a bi-functional optical-MRI contrast agent and a hybrid MRI-DOT system", Proc. SPIE 8574, Multimodal Biomedical Imaging VIII, 85740K (13 March 2013); https://doi.org/10.1117/12.2003606
Lens.org Logo
CITATIONS
Cited by 2 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Magnetic resonance imaging

Bladder

Diffuse optical tomography

Imaging systems

Optical imaging

Tissue optics

Absorption

Back to Top